Bayesian Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,000
| Closed | -$370K | – | 935 |
|
|
2024
Q4 | $370K | Buy |
+28,000
| New | +$370K | 0.05% | 442 |
|
|
2024
Q1 | – | Sell |
-15,116
| Closed | -$327K | – | 1093 |
|
|
2023
Q4 | $327K | Buy |
+15,116
| New | +$327K | 0.03% | 478 |
|
|
2023
Q3 | – | Sell |
-17,669
| Closed | -$370K | – | 981 |
|
|
2023
Q2 | $370K | Sell |
17,669
-995
| -5% | -$20.8K | 0.04% | 485 |
|
|
2023
Q1 | $394K | Sell |
18,664
-1,700
| -8% | -$35.9K | 0.05% | 452 |
|
|
2022
Q4 | $518K | Buy |
20,364
+9,487
| +87% | +$241K | 0.08% | 353 |
|
|
2022
Q3 | $261K | Buy |
+10,877
| New | +$261K | 0.05% | 457 |
|